Corteva (CTVA)
NYSE:CTVA
Want to see CTVA full AI Analyst Report?
CTVA Stock Chart & Stats
$80.34
-$0.33(-0.58%)
At close: 4:00 PM EST
$80.34
-$0.33(-0.58%)
Day’s Range― - ―
52-Week Range$60.54 - $85.63
Previous CloseN/A
Volume628.04K
Average Volume (3M)4.02M
Market Cap
$54.28B
Enterprise Value$52.92B
Total Cash (Recent Filing)$4.53B
Total Debt (Recent Filing)$2.58B
Price to Earnings (P/E)41.2
Beta0.50
Next Earnings
May 05, 2026EPS Estimate
1.17Next Dividend Ex-DateN/A
Dividend Yield1.04%
Share Statistics
EPS (TTM)1.59
Shares Outstanding671,356,500
10 Day Avg. Volume3,576,251
30 Day Avg. Volume4,019,329
Financial Highlights & Ratios
PEG Ratio1.80
Price to Book (P/B)1.87
Price to Sales (P/S)2.59
P/FCF Ratio16.03
Enterprise Value/Market Cap0.98
Enterprise Value/Revenue3.04
Enterprise Value/Gross Profit6.56
Enterprise Value/Ebitda17.23
Forecast
1Y Price Target
$87.58Price Target Upside9.02% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering14
EPS Forecast (FY)3.66
Revenue Forecast (FY)$18.09B
Bulls Say, Bears Say
Bulls Say
Conservative Guidance Enabling UpgradesAnalyst points out conservative company guidance leaves room for upward estimate revisions if agricultural conditions and currency trends remain supportive.
Improved Cash Flow And Working CapitalStrong free cash flow and significantly improved working capital enhance financial flexibility to support buybacks, debt reduction, or strategic investments.
Seed Valuation UpsideAnalyst highlights that the Seed business has been performing strongly and could command a higher valuation multiple once separated, supporting potential upside for the stock.
Bears Say
Crop Chemicals Standalone PressureCrop Chemicals may face sales and volume pressure as a standalone business without a clear peer, increasing the likelihood of derating and margin compression.
Separation Execution RiskPlanned split of Seed and Crop Chemicals introduces execution risk, with potential loss of synergies and higher operating costs that could pressure the stock.
Valuation Concerns And Analyst DowngradesAnalyst downgrades to Neutral on valuation concerns and views the risk-reward as more balanced, which could limit further price appreciation.
Corteva News
CTVA FAQ
What was Corteva’s price range in the past 12 months?
Corteva lowest stock price was $60.53 and its highest was $85.63 in the past 12 months.
What is Corteva’s market cap?
Corteva’s market cap is $54.28B.
When is Corteva’s upcoming earnings report date?
Corteva’s upcoming earnings report date is May 05, 2026 which is today.
How were Corteva’s earnings last quarter?
Currently, no data Available
Is Corteva overvalued?
According to Wall Street analysts Corteva’s price is currently Undervalued.
Does Corteva pay dividends?
Corteva pays a Quarterly dividend of $0.18 which represents an annual dividend yield of 1.04%. See more information on Corteva dividends here
What is Corteva’s EPS estimate?
Corteva’s EPS estimate is 1.17.
How many shares outstanding does Corteva have?
Corteva has 671,356,500 shares outstanding.
What happened to Corteva’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Corteva?
Currently, no hedge funds are holding shares in CTVA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Corteva Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$87.58 (9.02% Upside)
$87.58 (9.02% Upside)
Blogger Sentiment
Bullish
CTVA Sentiment 100%
Sector Average 75%
Sector Average 75%
Hedge Fund Trend
Decreased
By 786.9K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $636.2K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 0.8%
Last 30 Days ▼ 7.2%
Last 30 Days ▼ 7.2%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
35.80%
12-Months-Change
Fundamentals
Return on Equity
4.40%
Trailing 12-Months
Asset Growth
4.95%
Trailing 12-Months
Company Description
Corteva
Corteva, Inc. operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics. This segment also provides digital solutions that assist farmer decision-making with a view to optimize product selection, and maximize yield and profitability. The Crop Protection segment offers products that protect against weeds, insects and other pests, and diseases, as well as enhances crop health above and below ground through nitrogen management and seed-applied technologies. This segment provides herbicides, insecticides, nitrogen stabilizers, and pasture and range management herbicides. It serves agricultural input industry. The company operates in the United States, Canada, Latin America, the Asia Pacific, Europe, the Middle East, and Africa. Corteva, Inc. was incorporated in 2018 and is headquartered in Indianapolis, Indiana.
CTVA Company Deck
CTVA Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed a broadly positive outlook driven by strong 2025 results (14% EBITDA growth, margin expansion to >22%, $2.9B FCF), successful strategic progress (Bayer settlement accelerating licensing and reducing royalty risk), and reiterated 2026 guidance with continued productivity targets. Key near-term risks include Q4 timing-related volume softness, competitive pricing pressures in Crop Protection (notably Brazil), currency headwinds in 2025 and expected tariff impacts in 2026, along with higher SG&A/R&D and potential normalization of working capital that could temper free cash flow. On balance, the company highlighted more material progress and upside catalysts than offsets, with a clear path to additional licensing revenue and margin/cash improvement.View all CTVA earnings summariesCTVA Revenue Breakdown
40.24% Corn
10.79% Soybean
3.70% Other oilseeds
2.15% Other
21.44% Herbicides
9.59% Insecticides
6.55% Fungicides
2.98% Biologicals
2.56% Other
CTVA Stock 12 Month Forecast
Average Price Target
$87.58
▲(9.02% Upside)
Technical Analysis
Ownership Overview
0.17% Insiders
28.03% Mutual Funds
3.38% Other Institutional Investors
43.68% Public Companies and
Individual Investors